Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PIK3CB amplification
i
Other names:
PIK3CB, Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta, Phosphatidylinositol 4,5-Bisphosphate 3-Kinase 110 KDa Catalytic Subunit Beta, Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta Isoform, Phosphoinositide-3-Kinase, Catalytic, Beta Polypeptide, PtdIns-3-Kinase Subunit P110-Beta, PtdIns-3-Kinase Subunit Beta, PI3-Kinase Subunit Beta, PI3K-Beta, PIK3C1, PI3-Kinase P110 Subunit Beta, PtdIns-3-Kinase P110, P110BETA, PI3KBETA, PI3Kbeta, P110beta
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5291
Related biomarkers:
Expression
Mutation
‹
›
Associations
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
PIK3CB amplification
Prostate Cancer
PIK3CB amplification
Prostate Cancer
nivolumab
Resistant: C3 – Early Trials
AACR 2023 - 1 week (New C3)
nivolumab
Resistant
:
C3
AACR 2023 - 1wk
nivolumab
Resistant: C3 – Early Trials
AACR 2023 - 1 week
nivolumab
Resistant
:
C3
AACR 2023 - 1 week - (New C3)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login